None listed
Conditions
Interventions
Subjects take a can of two kinds of functional foods containing beverage once in a day. After 6-days washout, subjects take a can of placebo beverage once in a day. After 6-days washout, subjects take
Sponsors
Suntory Global Innovation Center Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Healthy males aged 20 or more and less than 65 years-old. 2)Subjects with fasting blood glucose level 100 mg/dL or more and less than 126 mg/dL 3)Subjects who can visit hospital on designated day. 4)Subjects giving written informed consent.
Exclusion criteria
Exclusion criteria: 1)Subjects with constant drug treatment. 2)Subjects who are contracting diabetes. 3)Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting the test results. 4)Subjects with a previous history of disease on heart, liver, kidney or digestive organs. 5)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. 6)Subjects who drink alcohol a lot and smoke a lot. 7)Subjects who have an irregular sleep cycle, work shift or work on midnight shift. 8)Subjects who have allergic reaction to drug medicine and food. 9)Subjects whose systolic blood pressure is less than 90mmHg. 10)Subjects who donated 200 mL of blood and/or blood components within four weeks prior to the current study. 11)Male subjects whose blood was collected more than 400 mL within the last twelve weeks. 12)Female subjects whose blood was collected more than 400 mL within the last sixteen weeks. 13)Male subjects whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added. 14)Female subjects whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added. 15)Subjects who are participating in other clinical studies for drug medicine or food, or who finished clinical study within four weeks. 16)Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy : Area under the curve of delta blood glucose level. Safety : Incidence of adverse effects | — |
Countries
Japan
Contacts
Public ContactHiroshi Watanabe
Suntory Global Innovation Center Ltd. Innovation Development Department
Outcome results
None listed